These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15506346)

  • 21. [Cardiac peptides--seen from the basic point of view].
    Gøtze JP; Rehfeld JF
    Ugeskr Laeger; 2003 Aug; 165(35):3324-5. PubMed ID: 14531372
    [No Abstract]   [Full Text] [Related]  

  • 22. [Arrhythmias and natriuretic polypeptides].
    Horie M
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():101-2. PubMed ID: 15506347
    [No Abstract]   [Full Text] [Related]  

  • 23. [Countermeasure for severe acute cardiomyopathies].
    Nakano T; Yamakado T
    Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):235-9. PubMed ID: 8098351
    [No Abstract]   [Full Text] [Related]  

  • 24. Relation between angiotensin-converting enzyme II genotype and atrial fibrillation in Japanese patients with hypertrophic cardiomyopathy.
    Ogimoto A; Hamada M; Nakura J; Miki T; Hiwada K
    J Hum Genet; 2002; 47(4):184-9. PubMed ID: 12166654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
    Kohno M; Horio T; Yokokawa K; Yasunari K; Ikeda M; Minami M; Kurihara N; Takeda T
    Am J Med; 1995 Mar; 98(3):257-65. PubMed ID: 7872342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Measurement of natriuretic peptides].
    Harada M; Nakao K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():47-50. PubMed ID: 15506335
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma ANP and BNP during exercise in patients with major depressive disorder and in healthy controls.
    Wisén AG; Ekberg K; Wohlfart B; Ekman R; Westrin A
    J Affect Disord; 2011 Mar; 129(1-3):371-5. PubMed ID: 20875919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-type natriuretic peptide: from bench to bedside.
    Adams KF; Mathur VS; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S34-46. PubMed ID: 12594450
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pathophysiology of congestive heart failure].
    Luzza F; Bruni F; Rizzo F; Carerj S
    Minerva Cardioangiol; 2002 Jun; 50(3):209-19. PubMed ID: 12107401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac peptides and plasma renin activity in acute dilated cardiomyopathy.
    Missouris CG; Varma C; Ward D; MacGregor GA
    Eur J Heart Fail; 2001 Jan; 3(1):109-11. PubMed ID: 11163744
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diagnosis of heart failure with the help of natriuretic peptides. Practical tool in primary health care].
    Theodorsson E
    Lakartidningen; 2001 Oct; 98(41):4427. PubMed ID: 11699247
    [No Abstract]   [Full Text] [Related]  

  • 33. Practical implications of current natriuretic peptide research.
    Sagnella GA
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):304-15. PubMed ID: 11967816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are natriuretic peptides clinically useful as markers of heart failure?
    Kelly R; Struthers AD
    Ann Clin Biochem; 2001 Mar; 38(Pt 2):94-102. PubMed ID: 11269761
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?
    Wong F; Siu S; Liu P; Blendis LM
    Clin Sci (Lond); 2001 Dec; 101(6):621-8. PubMed ID: 11724649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are natriuretic peptides clinically useful as markers of heart failure?
    Kelly R; Struthers AD
    Ann Clin Biochem; 2001 Sep; 38(Pt 5):575-83. PubMed ID: 11587142
    [No Abstract]   [Full Text] [Related]  

  • 38. [Atrial natriuretic peptide as angiotensin II antagonist. A new therapeutic principle?].
    Pfaffendorf M
    Med Monatsschr Pharm; 1992 Jun; 15(6):169-77. PubMed ID: 1535414
    [No Abstract]   [Full Text] [Related]  

  • 39. The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure.
    Vaz Pérez A; Doehner W; von Haehling S; Schmidt H; Zimmermann AV; Volk HD; Anker SD; Rauchhaus M
    Int J Cardiol; 2010 May; 141(1):39-43. PubMed ID: 19155075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Medical treatment for cardiomyopathies].
    Suwa M
    Nihon Rinsho; 2000 Jan; 58(1):59-63. PubMed ID: 10885289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.